Camlin Fine Sciences Intrinsic Value
Camlin Fine Sciences (CAMLINFINE) median intrinsic value is ₹253.16 from 9 valuation models (range ₹118–₹380), vs current price ₹126.58 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse CAMLINFINE FII DII holdings to track promoter, FII and institutional holdings.
CAMLINFINE Valuation Methods Summary — DCF, Graham Number & P/E
Camlin Fine Sciences intrinsic value across 9 models vs current price ₹126.58 — upside/downside and value range per method. Read CAMLINFINE dividend payout details for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹220.32 | ₹176.26 - ₹264.38 | +74.1% | EPS: ₹18.36, Sector P/E: 12x |
| Book Value Method | asset | ₹316.45 | ₹284.81 - ₹348.10 | +150.0% | Book Value/Share: ₹526.84, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹253.16 | ₹227.84 - ₹278.48 | +100.0% | Revenue/Share: ₹1126.32, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹253.16 | ₹227.84 - ₹278.48 | +100.0% | EBITDA: ₹496.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹316.45 | ₹253.16 - ₹379.74 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹117.50 | ₹105.75 - ₹129.25 | -7.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹151.29 | ₹136.16 - ₹166.42 | +19.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹253.16 | ₹227.84 - ₹278.48 | +100.0% | ROE: 34.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹379.74 | ₹341.77 - ₹417.71 | +200.0% | EPS: ₹18.36, BVPS: ₹526.84 |
CAMLINFINE Intrinsic Value vs Market Price — All Valuation Models
Camlin Fine Sciences fair value range ₹118–₹380 vs current market price ₹126.58 across 9 valuation models. For current market price and key ratios, visit Camlin Fine Sciences stock price NSE.
CAMLINFINE Intrinsic Value Analysis — Undervalued or Overvalued?
Camlin Fine Sciences median intrinsic value ₹253.16, current price ₹126.58 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CAMLINFINE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Camlin Fine Sciences (CAMLINFINE) is ₹253.16 (median value). With the current market price of ₹126.58, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹117.50 to ₹379.74, indicating ₹117.50 - ₹379.74.
Is CAMLINFINE undervalued or overvalued?
Based on our multi-method analysis, Camlin Fine Sciences (CAMLINFINE) appears to be trading below calculated value by approximately 100.0%.
CAMLINFINE Financial Health — Key Ratios vs Industry Benchmarks
Camlin Fine Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.54 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 34.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.92x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAMLINFINE Cash Flow Quality — Operating & Free Cash Flow
Camlin Fine Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹82 Cr | ₹56 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹23 Cr | ₹-15 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹139 Cr | ₹106 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹51 Cr | ₹-12 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹145 Cr | ₹21 Cr | Positive Free Cash Flow | 7/10 |